SAR428926
/ Sanofi, AbbVie
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 12, 2017
A Study of SAR428926 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1; N=110; Recruiting; Sponsor: Sanofi; Trial primary completion date: Aug 2019 ➔ Dec 2019
Trial primary completion date • Biosimilar • Breast Cancer • Colorectal Cancer • Gastrointestinal Cancer • HER2 Breast Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • Triple Negative Breast Cancer
1 to 1
Of
1
Go to page
1